| (Values in U.S. Thousands) | Mar, 2025 | Sep, 2024 | Mar, 2024 | Sep, 2023 | Mar, 2023 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | 0 | 0 | 0 | 0 | 0 |
| Net Income Growth | unch | unch | unch | unch | unch |
Assura Plc (AGR.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Assura PLC is a healthcare facility REIT. The company operates one segment that develops, owns, and manages primary-care properties. All the company's revenue is generated in the United Kingdom. Assura seeks properties that are characterized by a secure and predictable income stream with an underpinning of inflation linkage. The company considers merger and acquisition investment to be a component of its operational growth strategy. It engages in relationship-building with general practitioners to secure investment opportunities.
Fiscal Year End Date: 03/31